4//SEC Filing
MEI Pharma, Inc. 4
Accession 0001209191-17-044519
$LITSCIK 0001262104operating
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 2:24 PM ET
Size
9.2 KB
Accession
0001209191-17-044519
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
GOLD DANIEL P PHD
DirectorPresident and Chief Executive
Transactions
- Award
Option to purchase shares of common stock
2017-07-06+380,000→ 1,234,166 totalExercise: $2.83Exp: 2027-07-06→ Common Stock par value $0.00000002 (380,000 underlying)
Footnotes (2)
- [F1]One-quarter of the options will vest on July 6, 2018; the remaining three-quarters of the options will vest in equal monthly installments over the following thirty-six months.
- [F2]The total number of derivative securities reported in Column 9 includes previously awarded options, which were subject to the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012.
Issuer
MEI Pharma, Inc.
CIK 0001262104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001262104
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 2:24 PM ET
- Size
- 9.2 KB